 | • レポートコード：GIR-22F19121 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Amlodipine and Olmesartan Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界のアムロジピン＆オルメサルタンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 アムロジピン＆オルメサルタン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・5/20mg錠、10/20mg錠、5/40mg錠、10/40mg錠 アプリケーション別セグメントは次のように区分されます。 ・病院、ドラッグストア 世界のアムロジピン＆オルメサルタン市場の主要な市場プレーヤーは以下のとおりです。 ・Daiichi Sankyo、Teva、Glenmark Pharmaceuticals、Matrix Laboratories、Torrent Pharmaceuticals、Aurobindo、Macleods Pharmaceuticals、Alembic Pharmaceuticals、Ajanta Pharma、Jubilant Pharma、Accord Healthcare 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、アムロジピン＆オルメサルタン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なアムロジピン＆オルメサルタンメーカーの企業概要、2019年～2022年までのアムロジピン＆オルメサルタンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なアムロジピン＆オルメサルタンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別アムロジピン＆オルメサルタンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのアムロジピン＆オルメサルタンのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアムロジピン＆オルメサルタン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびアムロジピン＆オルメサルタンの産業チェーンを掲載しています。 ・第13、14、15章では、アムロジピン＆オルメサルタンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - アムロジピン＆オルメサルタンの概要 - タイプ別分析（2017年vs2021年vs2028年）：5/20mg錠、10/20mg錠、5/40mg錠、10/40mg錠 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、ドラッグストア - 世界のアムロジピン＆オルメサルタン市場規模・予測 - 世界のアムロジピン＆オルメサルタン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Daiichi Sankyo、Teva、Glenmark Pharmaceuticals、Matrix Laboratories、Torrent Pharmaceuticals、Aurobindo、Macleods Pharmaceuticals、Alembic Pharmaceuticals、Ajanta Pharma、Jubilant Pharma、Accord Healthcare ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：5/20mg錠、10/20mg錠、5/40mg錠、10/40mg錠 ・アプリケーション別分析2017年-2028年：病院、ドラッグストア ・アムロジピン＆オルメサルタンの北米市場分析 - アムロジピン＆オルメサルタンの北米市場：タイプ別市場規模2017年-2028年 - アムロジピン＆オルメサルタンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・アムロジピン＆オルメサルタンのヨーロッパ市場分析 - ：アムロジピン＆オルメサルタンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：アムロジピン＆オルメサルタンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・アムロジピン＆オルメサルタンのアジア太平洋市場分析 - アムロジピン＆オルメサルタンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - アムロジピン＆オルメサルタンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・アムロジピン＆オルメサルタンの南米市場分析 - アムロジピン＆オルメサルタンの南米市場：タイプ別市場規模2017年-2028年 - アムロジピン＆オルメサルタンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・アムロジピン＆オルメサルタンの中東・アフリカ市場分析 - アムロジピン＆オルメサルタンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - アムロジピン＆オルメサルタンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Amlodipine and Olmesartan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Amlodipine and Olmesartan market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Amlodipine and Olmesartan global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5/20 mg Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Amlodipine and Olmesartan include Daiichi Sankyo, Teva, Glenmark Pharmaceuticals, Matrix Laboratories, and Torrent Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Amlodipine and Olmesartan market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5/20 mg Tablets
10/20 mg Tablets
5/40 mg Tablets
10/40 mg Tablets
Market segment by Application can be divided into
Hospital
Drug store
The key market players for global Amlodipine and Olmesartan market are listed below:
Daiichi Sankyo
Teva
Glenmark Pharmaceuticals
Matrix Laboratories
Torrent Pharmaceuticals
Aurobindo
Macleods Pharmaceuticals
Alembic Pharmaceuticals
Ajanta Pharma
Jubilant Pharma
Accord Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Amlodipine and Olmesartan product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Amlodipine and Olmesartan, with price, sales, revenue and global market share of Amlodipine and Olmesartan from 2019 to 2022.
Chapter 3, the Amlodipine and Olmesartan competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amlodipine and Olmesartan breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Amlodipine and Olmesartan market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Amlodipine and Olmesartan.
Chapter 13, 14, and 15, to describe Amlodipine and Olmesartan sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Amlodipine and Olmesartan Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Amlodipine and Olmesartan Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5/20 mg Tablets
1.2.3 10/20 mg Tablets
1.2.4 5/40 mg Tablets
1.2.5 10/40 mg Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Amlodipine and Olmesartan Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Amlodipine and Olmesartan Market Size & Forecast
1.4.1 Global Amlodipine and Olmesartan Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Amlodipine and Olmesartan Sales in Volume (2017-2028)
1.4.3 Global Amlodipine and Olmesartan Price (2017-2028)
1.5 Global Amlodipine and Olmesartan Production Capacity Analysis
1.5.1 Global Amlodipine and Olmesartan Total Production Capacity (2017-2028)
1.5.2 Global Amlodipine and Olmesartan Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Amlodipine and Olmesartan Market Drivers
1.6.2 Amlodipine and Olmesartan Market Restraints
1.6.3 Amlodipine and Olmesartan Trends Analysis
2 Manufacturers Profiles
2.1 Daiichi Sankyo
2.1.1 Daiichi Sankyo Details
2.1.2 Daiichi Sankyo Major Business
2.1.3 Daiichi Sankyo Amlodipine and Olmesartan Product and Services
2.1.4 Daiichi Sankyo Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Amlodipine and Olmesartan Product and Services
2.2.4 Teva Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Glenmark Pharmaceuticals
2.3.1 Glenmark Pharmaceuticals Details
2.3.2 Glenmark Pharmaceuticals Major Business
2.3.3 Glenmark Pharmaceuticals Amlodipine and Olmesartan Product and Services
2.3.4 Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Matrix Laboratories
2.4.1 Matrix Laboratories Details
2.4.2 Matrix Laboratories Major Business
2.4.3 Matrix Laboratories Amlodipine and Olmesartan Product and Services
2.4.4 Matrix Laboratories Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Torrent Pharmaceuticals
2.5.1 Torrent Pharmaceuticals Details
2.5.2 Torrent Pharmaceuticals Major Business
2.5.3 Torrent Pharmaceuticals Amlodipine and Olmesartan Product and Services
2.5.4 Torrent Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Aurobindo
2.6.1 Aurobindo Details
2.6.2 Aurobindo Major Business
2.6.3 Aurobindo Amlodipine and Olmesartan Product and Services
2.6.4 Aurobindo Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Macleods Pharmaceuticals
2.7.1 Macleods Pharmaceuticals Details
2.7.2 Macleods Pharmaceuticals Major Business
2.7.3 Macleods Pharmaceuticals Amlodipine and Olmesartan Product and Services
2.7.4 Macleods Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Alembic Pharmaceuticals
2.8.1 Alembic Pharmaceuticals Details
2.8.2 Alembic Pharmaceuticals Major Business
2.8.3 Alembic Pharmaceuticals Amlodipine and Olmesartan Product and Services
2.8.4 Alembic Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Ajanta Pharma
2.9.1 Ajanta Pharma Details
2.9.2 Ajanta Pharma Major Business
2.9.3 Ajanta Pharma Amlodipine and Olmesartan Product and Services
2.9.4 Ajanta Pharma Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business
2.10.3 Jubilant Pharma Amlodipine and Olmesartan Product and Services
2.10.4 Jubilant Pharma Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Accord Healthcare
2.11.1 Accord Healthcare Details
2.11.2 Accord Healthcare Major Business
2.11.3 Accord Healthcare Amlodipine and Olmesartan Product and Services
2.11.4 Accord Healthcare Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Amlodipine and Olmesartan Breakdown Data by Manufacturer
3.1 Global Amlodipine and Olmesartan Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Amlodipine and Olmesartan Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Amlodipine and Olmesartan
3.4 Market Concentration Rate
3.4.1 Top 3 Amlodipine and Olmesartan Manufacturer Market Share in 2021
3.4.2 Top 6 Amlodipine and Olmesartan Manufacturer Market Share in 2021
3.5 Global Amlodipine and Olmesartan Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Amlodipine and Olmesartan Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Amlodipine and Olmesartan Market Size by Region
4.1.1 Global Amlodipine and Olmesartan Sales in Volume by Region (2017-2028)
4.1.2 Global Amlodipine and Olmesartan Revenue by Region (2017-2028)
4.2 North America Amlodipine and Olmesartan Revenue (2017-2028)
4.3 Europe Amlodipine and Olmesartan Revenue (2017-2028)
4.4 Asia-Pacific Amlodipine and Olmesartan Revenue (2017-2028)
4.5 South America Amlodipine and Olmesartan Revenue (2017-2028)
4.6 Middle East and Africa Amlodipine and Olmesartan Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Amlodipine and Olmesartan Sales in Volume by Type (2017-2028)
5.2 Global Amlodipine and Olmesartan Revenue by Type (2017-2028)
5.3 Global Amlodipine and Olmesartan Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Amlodipine and Olmesartan Sales in Volume by Application (2017-2028)
6.2 Global Amlodipine and Olmesartan Revenue by Application (2017-2028)
6.3 Global Amlodipine and Olmesartan Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Amlodipine and Olmesartan Sales by Type (2017-2028)
7.2 North America Amlodipine and Olmesartan Sales by Application (2017-2028)
7.3 North America Amlodipine and Olmesartan Market Size by Country
7.3.1 North America Amlodipine and Olmesartan Sales in Volume by Country (2017-2028)
7.3.2 North America Amlodipine and Olmesartan Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Amlodipine and Olmesartan Sales by Type (2017-2028)
8.2 Europe Amlodipine and Olmesartan Sales by Application (2017-2028)
8.3 Europe Amlodipine and Olmesartan Market Size by Country
8.3.1 Europe Amlodipine and Olmesartan Sales in Volume by Country (2017-2028)
8.3.2 Europe Amlodipine and Olmesartan Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Amlodipine and Olmesartan Sales by Type (2017-2028)
9.2 Asia-Pacific Amlodipine and Olmesartan Sales by Application (2017-2028)
9.3 Asia-Pacific Amlodipine and Olmesartan Market Size by Region
9.3.1 Asia-Pacific Amlodipine and Olmesartan Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Amlodipine and Olmesartan Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Amlodipine and Olmesartan Sales by Type (2017-2028)
10.2 South America Amlodipine and Olmesartan Sales by Application (2017-2028)
10.3 South America Amlodipine and Olmesartan Market Size by Country
10.3.1 South America Amlodipine and Olmesartan Sales in Volume by Country (2017-2028)
10.3.2 South America Amlodipine and Olmesartan Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Amlodipine and Olmesartan Sales by Type (2017-2028)
11.2 Middle East & Africa Amlodipine and Olmesartan Sales by Application (2017-2028)
11.3 Middle East & Africa Amlodipine and Olmesartan Market Size by Country
11.3.1 Middle East & Africa Amlodipine and Olmesartan Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Amlodipine and Olmesartan Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Amlodipine and Olmesartan and Key Manufacturers
12.2 Manufacturing Costs Percentage of Amlodipine and Olmesartan
12.3 Amlodipine and Olmesartan Production Process
12.4 Amlodipine and Olmesartan Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Amlodipine and Olmesartan Typical Distributors
13.3 Amlodipine and Olmesartan Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer